Biological Products, (No Diagnostic Substances)
Standard Industrial Classification: SIC 2836
Industry Insider Sentiment Analysis
The Biological Products, (No Diagnostic Substances) sector (SIC 2836) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 20:50 | 2026-07-31 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% owner | BUY | $8.00 | 52,900 | $422,978 | 3,048,223 |
| 2026-08-03 22:26 | 2026-07-30 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Officer | SELL | $24.00 | 1,299 | $31,176 | 399,989 |
| 2026-07-31 21:13 | 2026-07-29 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $9.96 | 45,768 | $455,726 | 17,329,570 |
| 2026-07-31 20:15 | 2026-07-29 | DBVT | DBV Technologies S.A. | Mohideen Pharis | Officer | SELL | $2.70 | 464 | $1,253 | 144,531 |
| 2026-07-31 20:15 | 2026-07-29 | MAZE | Maze Therapeutics, Inc. | Dandekar Atul | Officer | OPT+S | $27.34 | 7,500 | $205,031 | 26,250 |
| 2026-07-31 20:05 | 2026-07-30 | VCEL | Vericel Corp | SIEGAL JONATHAN | Officer | OPT+S | $48.90 | 4,500 | $220,050 | 1,078 |
| 2026-07-30 21:29 | 2026-07-28 | NBIX | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | OPT+S | $182.01 | 1,250 | $227,508 | 1,588 |
| 2026-07-30 20:12 | 2026-07-28 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | Officer | SELL | $18.61 | 2,237 | $41,631 | 407,660 |
| 2026-07-30 20:13 | 2026-07-28 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | Officer | SELL | $18.61 | 748 | $13,920 | 228,165 |
| 2026-07-30 20:13 | 2026-07-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | Officer | SELL | $18.61 | 1,459 | $27,152 | 158,285 |
| 2026-07-30 01:05 | 2026-07-29 | BCDA | BioCardia, Inc. | Altman Peter | Director, Officer | BUY | $0.78 | 5,000 | $3,900 | 373,885 |
| 2026-07-29 23:09 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | AH Bio Fund II, L.P. | 10% owner | BUY | $15.00 | 333,333 | $4,999,995 | 2,385,075 |
| 2026-07-29 22:47 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | BUY | $15.00 | 1,000,000 | $15,000,000 | 1,348,825 |
| 2026-07-29 22:50 | 2026-07-27 | SCTX | Scribe Therapeutics, Inc. | GORDON CARL L | Director | BUY | $15.00 | 1,000,000 | $15,000,000 | 1,348,825 |
| 2026-07-29 20:51 | 2026-07-28 | EDIT | Editas Medicine, Inc. | Burkly Linda | Officer | SELL | $2.67 | 4,928 | $13,158 | 62,369 |
| 2026-07-29 20:05 | 2026-07-27 | BEAM | Beam Therapeutics Inc. | Simon Amy | Officer | SELL | $25.74 | 16,667 | $429,037 | 85,696 |
| 2026-07-29 19:19 | 2026-07-29 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Director | BUY | $1.05 | 95,398 | $99,996 | 220,972 |
| 2026-07-29 01:30 | 2026-07-24 | SCTX | Scribe Therapeutics, Inc. | Aghazadeh Behzad | Director, 10% owner | BUY | $15.16 | 2,391,238 | $36,259,777 | 3,088,888 |
| 2026-07-28 21:24 | 2026-07-24 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $9.99 | 41,319 | $412,777 | 17,283,802 |
| 2026-07-28 20:05 | 2026-07-24 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% owner | BUY | $7.90 | 130 | $1,027 | 2,995,323 |
| 2026-07-28 20:10 | 2026-07-27 | PCVX | Vaxcyte, Inc. | PICKERING GRANT | Director, Officer | OPT+S | $55.63 | 18,198 | $1,012,375 | 133,215 |
| 2026-07-28 01:42 | 2026-07-23 | SCTX | Scribe Therapeutics, Inc. | Lucas Svetlana | Officer | BUY | $15.00 | 3,000 | $45,000 | 3,000 |
| 2026-07-28 01:20 | 2026-07-23 | SCTX | Scribe Therapeutics, Inc. | Parrot David | Officer | BUY | $15.00 | 2,666 | $39,990 | 1,333 |
| 2026-07-27 20:05 | 2026-07-23 | TWST | Twist Bioscience Corp | Finn Patrick John | Officer | SELL | $93.89 | 2,238 | $210,133 | 272,566 |
| 2026-07-25 01:00 | 2026-07-22 | SRZN | Surrozen, Inc./DE | TCG Crossover GP II, LLC | 10% owner | SELL | $21.25 | 325,000 | $6,906,250 | 574,047 |
| 2026-07-24 21:59 | 2026-07-24 | IMVT | Immunovant, Inc. | Pande Atul | Director | OPT+S | $39.80 | 1,500 | $59,700 | 116,731 |
| 2026-07-24 21:57 | 2026-07-23 | IMVT | Immunovant, Inc. | Stout Jay S | Officer | SELL | $38.69 | 2,857 | $110,537 | 205,341 |
| 2026-07-24 21:57 | 2026-07-23 | IMVT | Immunovant, Inc. | Girao Tiago | Officer | SELL | $38.69 | 6,798 | $263,015 | 240,798 |
| 2026-07-24 21:11 | 2026-07-22 | DYAI | DYADIC INTERNATIONAL INC | Francisco Trust under agreement dated February 28, 1996 | 10% owner | SELL | $1.31 | 95,392 | $124,954 | 3,280,272 |
| 2026-07-24 20:05 | 2026-07-22 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% owner | BUY | $7.82 | 200,086 | $1,565,493 | 2,995,193 |
| 2026-07-24 01:21 | 2026-07-13 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $8.94 | 6,522 | $58,307 | 16,817,543 |
| 2026-07-24 01:22 | 2026-07-21 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $9.76 | 264,586 | $2,583,312 | 17,242,483 |
| 2026-07-23 23:34 | 2026-07-21 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | Officer | OPT+S | $21.89 | 492,400 | $10,780,409 | 812,058 |
| 2026-07-23 13:34 | 2026-07-22 | GRML | Greenland Mines Ltd | Sawyer Jason David | Director | BUY | $0.23 | 240,000 | $55,944 | 240,000 |
| 2026-07-22 01:12 | 2026-07-21 | MGTX | MeiraGTx Holdings plc | Giroux Richard | Officer | SELL | $12.51 | 56,000 | $700,560 | 908,530 |
| 2026-07-21 20:54 | 2026-07-16 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% owner | SELL | $19.75 | 213 | $4,207 | 4,501,882 |
| 2026-07-21 01:47 | 2026-07-16 | IMA | ImageneBio, Inc. | Lally Robert B | Officer | SELL | $5.42 | 3,196 | $17,334 | 55,582 |
| 2026-07-20 23:19 | 2026-07-16 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Officer | SELL | $23.00 | 5,000 | $115,000 | 401,288 |
| 2026-07-20 22:08 | 2026-07-16 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $8.93 | 160,354 | $1,432,122 | 16,977,927 |
| 2026-07-20 21:00 | 2026-07-17 | DNA | Ginkgo Bioworks Holdings, Inc. | Coen Steven P. | Officer | OPT+S | $7.90 | 752 | $5,943 | 51,438 |
| 2026-07-20 20:16 | 2026-07-17 | BCDA | BioCardia, Inc. | Altman Peter | Director, Officer | BUY | $0.83 | 500 | $415 | 368,885 |
| 2026-07-20 18:27 | 2026-07-20 | GRML | Greenland Mines Ltd | McGarity Jon | Director | BUY | $0.18 | 140,000 | $24,822 | 551,277 |
| 2026-07-17 20:15 | 2026-07-15 | CGON | CG Oncology, Inc. | POST LEONARD E | Director | OPT+S | $71.17 | 1,000 | $71,170 | 0 |
| 2026-07-17 23:23 | 2026-07-15 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | Officer | OPT+S | $22.59 | 105,762 | $2,389,164 | 230,713 |
| 2026-07-17 20:40 | 2026-07-16 | RGEN | REPLIGEN CORP | Garland Jason K | Officer | SELL | $150.00 | 530 | $79,500 | 18,829 |
| 2026-07-17 20:05 | 2026-07-16 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Director, Officer | SELL | $23.18 | 9,500 | $220,219 | 585,038 |
| 2026-07-17 15:12 | 2026-07-16 | GRML | Greenland Mines Ltd | LeBlanc Jeff | Officer | BUY | $0.18 | 1,400,000 | $245,280 | 4,820,342 |
| 2026-07-16 22:08 | 2026-07-15 | GILD | GILEAD SCIENCES, INC. | Dickinson Andrew D | Officer | SELL | $129.93 | 3,000 | $389,777 | 168,646 |
| 2026-07-16 20:45 | 2026-07-15 | MRNA | Moderna, Inc. | Hoge Stephen | Officer | OPT+S | $67.60 | 53,336 | $3,605,514 | 1,483,848 |
| 2026-07-16 20:54 | 2026-07-15 | GILD | GILEAD SCIENCES, INC. | Mercier Johanna | Officer | SELL | $129.92 | 3,000 | $389,758 | 121,234 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Biological Products, (No Diagnostic Substances) sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2836) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Biological Products, (No Diagnostic Substances)
Every transaction in the Biological Products, (No Diagnostic Substances) industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.